ro for glp-1 Launches Wegovy® Pill Through Integration with Novo Nordisk Serena Williams Touts GLP-1 Health

By reducing inflammation, improving blood sugar control, and targeting brain regions linked to addiction, GLP-1 agonists address root causes of multiple health issues

If any of these are missing, approach with extreme caution

Some GLP1 receptor agonists are approved for weight management in individuals without diabetes, but clinicians should weigh benefits, risks, and access considerations for each patient

is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire obesity-drug developer Metsera

Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes

Some patients also report hair thinning, which typically occurs after prolonged use at high dosages, and may reflect nutritional deficiencies rather than a direct pharmacologic effect, he adds